RUNX1 and acute myeloid leukemia: Due to the lack of detailed mutation information from pediatric AML samples, we could only check the mutation status available on five genes with high clinical relevance (FLT3, NPM1, KIT, CEBPA, and WT1) and on three oncogenic gene fusions (RUNX1-RUNX1T1, CBFB-MYH11, and PML-RARA).